Baxter Bros Inc Pfizer Inc Transaction History

Baxter Bros Inc

$762 Million
Q3 2024

A detailed history of Baxter Bros Inc transactions in Pfizer Inc stock. As of the latest transaction made, Baxter Bros Inc holds 63,919 shares of PFE stock, worth $1.64 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

63,919

Previous 64,675 1.17%

Holding current value

$1.64 Million

Previous $1.81 Million 2.21%

% of portfolio

0.24%

Previous 0.24%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$27.7 - $31.39 $20,941 - $23,730	-756 Reduced 1.17%	63,919 $1.85 Million
Q2 2024 Jul 15, 2024	SELL	$25.26 - $29.6 $27,306 - $31,997	-1,081 Reduced 1.64%	64,675 $1.81 Million
Q1 2024 Apr 26, 2024	SELL	$25.89 - $29.73 $9,631 - $11,059	-372 Reduced 0.56%	65,756 $1.82 Million
Q4 2023 May 17, 2024	BUY	$26.13 - $33.94 $9,720 - $12,625	372 Added 0.57%	66,128 $1.9 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $319,177 - $414,577	-12,215 Reduced 15.59%	66,128 $1.9 Million
Q3 2023 May 17, 2024	BUY	$32.09 - $37.51 $403,916 - $472,138	12,587 Added 19.14%	78,343 $2.6 Million
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $116,326 - $135,973	-3,625 Reduced 4.42%	78,343 $2.6 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $46,161 - $53,407	1,278 Added 1.58%	81,968 $3.01 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $125,457 - $163,326	3,185 Added 4.11%	80,690 $3.29 Million
Q4 2022 Jan 31, 2023	SELL	$41.75 - $54.5 $18,328 - $23,925	-439 Reduced 0.56%	77,505 $3.97 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $2.08 Million - $2.54 Million	47,584 Added 156.73%	77,944 $3.41 Million
Q2 2022 Jul 25, 2022	BUY	$46.53 - $55.17 $14,377 - $17,047	309 Added 1.03%	30,360 $1.59 Million
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $48,678 - $60,318	-1,064 Reduced 3.42%	30,051 $1.56 Million
Q4 2021 Jan 14, 2022	SELL	$41.32 - $61.25 $4,297 - $6,370	-104 Reduced 0.33%	31,115 $1.84 Million
Q3 2021 Oct 25, 2021	BUY	$39.25 - $50.42 $27,906 - $35,848	711 Added 2.33%	31,219 $1.34 Million
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $185,762 - $210,437	5,173 Added 20.42%	30,508 $1.2 Million
Q1 2021 Apr 23, 2021	BUY	$33.49 - $37.77 $93,370 - $105,302	2,788 Added 12.37%	25,335 $918,000
Q4 2020 Jan 25, 2021	BUY	$33.47 - $42.56 $99,774 - $126,871	2,981 Added 15.24%	22,547 $830,000
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $67,056 - $78,672	2,112 Added 12.1%	19,566 $718,000
Q2 2020 Jul 31, 2020	BUY	$30.12 - $36.54 $2,530 - $3,069	84 Added 0.48%	17,454 $571,000
Q1 2020 Apr 17, 2020	BUY	$27.03 - $38.62 $1,135 - $1,622	42 Added 0.24%	17,370 $567,000
Q4 2019 Jan 10, 2020	SELL	$32.92 - $37.36 $94,151 - $106,849	-2,860 Reduced 14.17%	17,328 $679,000
Q4 2019 Jan 09, 2020	BUY	$32.92 - $37.36 $94,447 - $107,185	2,869 Added 16.57%	20,188 $629,000
Q3 2019 Oct 21, 2019	BUY	$32.49 - $42.13 $3,541 - $4,592	109 Added 0.63%	17,319 $622,000
Q2 2019 Jul 29, 2019	SELL	$36.98 - $41.52 $18,342 - $20,593	-496 Reduced 2.8%	17,210 $746,000
Q1 2019 Apr 22, 2019	SELL	$37.5 - $41.2 $1,200 - $1,318	-32 Reduced 0.18%	17,706 $752,000
Q4 2018 Jan 22, 2019	BUY	$38.47 - $43.86 $89,865 - $102,456	2,336 Added 15.17%	17,738 $774,000
Q3 2018 Oct 11, 2018	SELL	$34.47 - $41.81 $53,635 - $65,056	-1,556 Reduced 9.18%	15,402 $679,000
Q2 2018 Jul 17, 2018	SELL	$32.98 - $35.16 $163,119 - $173,901	-4,946 Reduced 22.58%	16,958 $615,000
Q1 2018 May 16, 2018	BUY	$31.91 - $37.02 $266,639 - $309,339	8,356 Added 61.68%	21,904 $777,000
Q4 2017 Feb 01, 2018	SELL	$33.26 - $35.29 $372,678 - $395,424	-11,205 Reduced 45.27%	13,548 $491,000
Q3 2017 Oct 16, 2017	BUY	$31.0 - $34.15 $767,343 - $845,314	24,753	24,753 $884,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

News

Stay updated on Baxter Bros Inc with notifications on news.

Account